<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03420937</url>
  </required_header>
  <id_info>
    <org_study_id>IGA_LF_2016_021</org_study_id>
    <nct_id>NCT03420937</nct_id>
  </id_info>
  <brief_title>Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery</brief_title>
  <official_title>Deep Neuromuscular Block During General Anaesthesia in Laparoscopic (and Robotic Laparoscopic) Surgery and Its Potential Benefits for Certain Physiological Parameters in Perioperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Olomouc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Olomouc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to show, whether the use of the deep neuromuscular block in
      certain laparoscopic robot-assisted surgery can positively influence main physiological
      functions compared to the use of standard neuromuscular block. Secondary outcome is to find
      out whether the targeted specific reversal of neuromuscular block by sugammadex improves and
      fastens the post-operative recovery of the patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adequate muscle relaxation during general anaesthesia is crucial for easy, uncomplicated and
      safe laparoscopic and robot-assisted surgery. Perfect abdominal wall relaxation facilitates
      surgical working conditions, which makes surgery safer, faster and easier to perform. Besides
      this indirect advantage, there could be obvious benefit for patients. This is a result of
      decreased negative pathophysiological consequences of an increased intraabdominal pressure
      (capnoperitoneum) on important organ systems (cardiovascular, breathing system, kidneys etc.)
      Complete muscle relaxation during general anaesthesia can be achieved by using higher doses
      of rocuronium (non-depolarizing aminosteroid muscle relaxant) and special anaesthetic
      technique called deep neuromuscular block (DNMB). The primary focus of the project is to test
      the potential advantages of DNMB compared to standard relaxation technique. Safe and
      efficient use of NMBA is an important precondition in restoring a patient´s full muscle
      strength at the end of anaesthesia, to prevent effects of residual block. Modern practice of
      anaesthesia offers an option for complete and immediate rocuronium induced block reversal by
      using its specific antagonist - sugammadex. Combination of DNMB approach and sugammadex
      reversal also provide potential benefits for perioperative course and patient recovery after
      surgery. Secondary objective of the project is to verify this facts.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical conditions SRS</measure>
    <time_frame>Perioperative period</time_frame>
    <description>Describes the quality of surgical conditions as reported by surgeon</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraabdominal pressure IAP (mmHg)</measure>
    <time_frame>During surgery</time_frame>
    <description>Pressure in the abdominal cavity during capnoperitoneum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operating theatre time (min)</measure>
    <time_frame>during anesthesia</time_frame>
    <description>Time from induction to anesthesia to the release from operating theatre</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative recovery</measure>
    <time_frame>post-operative period (1 week)</time_frame>
    <description>Physiological functions, level of discomfort, subjective evaluation by the patient</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">138</enrollment>
  <condition>Observation of Neuromuscular Block</condition>
  <condition>Complication of Ventilation Therapy</condition>
  <condition>Postoperative Recovery</condition>
  <arm_group>
    <arm_group_label>Deep Neuromuscular Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of rocuronium 0,6 mg/kg iv, top-ups 5-10 mg iv to target value of Post-tetanic Count (PTC) = 1-2; PTC measurement every 4 min.
Intervention: Neuromuscular blockade reversal at the end of anesthesia: sugammadex 2 mg/kg iv (when PTC is 18-20 and TOF-count 0) or sugammadex 4 mg/kg iv (when PTC under 18).
Induction of anesthesia: midazolam 1-2 mg iv, sufentanil 10-30 mcg iv, propofol 1,5-2,5 mg/kg iv Anesthesia: sevoflurane in air to target 1.2-1.5 minimal alveolar concentration (MAC). Rescue medication: sevoflurane, propofol 20-40 mg iv.
Extubation when patient is conscious and attained recovery from neuromuscular blockade to a TOF-ratio of at least 0,9.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate Neuromuscular Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of rocuronium 0,6 mg/kg iv, top-ups 5-10 mg iv to target value of Train-of-Four (TOF) count = 1-2, TOF-count measurement every 1 min. Intervention: Neuromuscular blockade reversal at the end of anesthesia: neostigmine 0.03 mg/kg iv + atropine 0.5-1.0 mg iv Induction of anesthesia: midazolam 1-2 mg iv, sufentanil 10-30 mcg iv, propofol 1.5-2.5 mg/kg iv Anesthesia: sevoflurane in air to target 1.2-1.5 minimal alveolar concentration (MAC). Rescue medication: sevoflurane, propofol 20-40 mg iv Extubation when patient is conscious and attained the recovery from neuromuscular blockade to a TOF-ratio of at least 0,9.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <description>Deep neuromuscular block provided by rocuronium to PTC 1-2. Reversal of the block with sugammadex.</description>
    <arm_group_label>Deep Neuromuscular Block</arm_group_label>
    <other_name>Bridion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine, Atropin Biotika</intervention_name>
    <description>Standard neuromuscular block provided by rocuronium to TOF-count 1-2. Reversal of the block with neostigmine.</description>
    <arm_group_label>Moderate Neuromuscular Block</arm_group_label>
    <other_name>syntostigmine, atropine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years

          -  Informed Consent

          -  Elective robotic radical prostatectomy

          -  American Society of Anesthesiologists (ASA) status 1-3

        Exclusion Criteria:

          -  Inability to obtain Informed ConsentAge under 18 years

          -  American Society of Anesthesiologists (ASA) status over 3

          -  Indication for rapid sequence induction, signs of difficult airway severe
             neuromuscular, liver or renal disease

          -  Known allergy to drugs used in the study

          -  Malignant hyperthermia (medical history)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karel Axmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Olomouc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>77520</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <reference>
    <citation>Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007 Aug;51(7):789-808.</citation>
    <PMID>17635389</PMID>
  </reference>
  <reference>
    <citation>Blobner M, Frick CG, Stäuble RB, Feussner H, Schaller SJ, Unterbuchner C, Lingg C, Geisler M, Fink H. Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc. 2015 Mar;29(3):627-36. doi: 10.1007/s00464-014-3711-7. Epub 2014 Aug 15.</citation>
    <PMID>25125097</PMID>
  </reference>
  <reference>
    <citation>Van Wijk RM, Watts RW, Ledowski T, Trochsler M, Moran JL, Arenas GW. Deep neuromuscular block reduces intra-abdominal pressure requirements during laparoscopic cholecystectomy: a prospective observational study. Acta Anaesthesiol Scand. 2015 Apr;59(4):434-40. doi: 10.1111/aas.12491. Epub 2015 Feb 13.</citation>
    <PMID>25684372</PMID>
  </reference>
  <reference>
    <citation>Madsen MV, Gätke MR, Springborg HH, Rosenberg J, Lund J, Istre O. Optimising abdominal space with deep neuromuscular blockade in gynaecologic laparoscopy--a randomised, blinded crossover study. Acta Anaesthesiol Scand. 2015 Apr;59(4):441-7. doi: 10.1111/aas.12493. Epub 2015 Mar 1.</citation>
    <PMID>25789421</PMID>
  </reference>
  <reference>
    <citation>Staehr-Rye AK, Rasmussen LS, Rosenberg J, Juul P, Lindekaer AL, Riber C, Gätke MR. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesth Analg. 2014 Nov;119(5):1084-92. doi: 10.1213/ANE.0000000000000316. Erratum in: Anesth Analg. 2015 Apr;120(4):957. Dosage error in article text.</citation>
    <PMID>24977638</PMID>
  </reference>
  <reference>
    <citation>Gerges FJ, Kanazi GE, Jabbour-Khoury SI. Anesthesia for laparoscopy: a review. J Clin Anesth. 2006 Feb;18(1):67-78. Review.</citation>
    <PMID>16517337</PMID>
  </reference>
  <reference>
    <citation>Gainsburg DM. Anesthetic concerns for robotic-assisted laparoscopic radical prostatectomy. Minerva Anestesiol. 2012 May;78(5):596-604. Epub 2012 Mar 13. Review.</citation>
    <PMID>22415437</PMID>
  </reference>
  <reference>
    <citation>Carron M. Respiratory benefits of deep neuromuscular block during laparoscopic surgery in a patient with end-stage lung disease. Br J Anaesth. 2015 Jan;114(1):158-9. doi: 10.1093/bja/aeu419.</citation>
    <PMID>25500396</PMID>
  </reference>
  <reference>
    <citation>Kilpatrick B, Slinger P. Lung protective strategies in anaesthesia. Br J Anaesth. 2010 Dec;105 Suppl 1:i108-16. doi: 10.1093/bja/aeq299. Review.</citation>
    <PMID>21148650</PMID>
  </reference>
  <reference>
    <citation>Futier E, Constantin JM, Jaber S. Protective lung ventilation in operating room: a systematic review. Minerva Anestesiol. 2014 Jun;80(6):726-35. Epub 2013 Nov 13. Review.</citation>
    <PMID>24226493</PMID>
  </reference>
  <reference>
    <citation>Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008 Jul;107(1):130-7. doi: 10.1213/ane.0b013e31816d1268.</citation>
    <PMID>18635478</PMID>
  </reference>
  <reference>
    <citation>Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol. 2010 Oct;27(10):874-81. doi: 10.1097/EJA.0b013e32833d56b7.</citation>
    <PMID>20683334</PMID>
  </reference>
  <reference>
    <citation>Rahe-Meyer N, Berger C, Wittmann M, Solomon C, Abels EA, Rietbergen H, Reuter DA. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery. Anaesthesist. 2015 Jul;64(7):506-12. doi: 10.1007/s00101-015-0048-0. Epub 2015 Jul 1.</citation>
    <PMID>26126940</PMID>
  </reference>
  <reference>
    <citation>Kopman AF, Naguib M. Laparoscopic surgery and muscle relaxants: is deep block helpful? Anesth Analg. 2015 Jan;120(1):51-8. doi: 10.1213/ANE.0000000000000471. Review.</citation>
    <PMID>25625254</PMID>
  </reference>
  <reference>
    <citation>Carron M, Ori C. Deep Neuromuscular Blockade for Laparoscopy: A Different View. Anesth Analg. 2016 Jan;122(1):289. doi: 10.1213/ANE.0000000000000864.</citation>
    <PMID>26678476</PMID>
  </reference>
  <results_reference>
    <citation>Dubois PE, Putz L, Jamart J, Marotta ML, Gourdin M, Donnez O. Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. Eur J Anaesthesiol. 2014 Aug;31(8):430-6. doi: 10.1097/EJA.0000000000000094.</citation>
    <PMID>24809482</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Olomouc</investigator_affiliation>
    <investigator_full_name>MUDr. Lenka Doubravska</investigator_full_name>
    <investigator_title>MUDr. Lenka Doubravská</investigator_title>
  </responsible_party>
  <keyword>deep neuromuscular block</keyword>
  <keyword>laparoscopic surgery</keyword>
  <keyword>robotic surgery</keyword>
  <keyword>lung protective ventilation</keyword>
  <keyword>respiratory functions</keyword>
  <keyword>post-operative recovery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

